Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
View ORCID ProfileI Van Walle, K Leitmeyer, View ORCID ProfileE K Broberg on behalf of the European COVID-19 microbiological laboratories group
doi: https://doi.org/10.1101/2020.09.16.20195917
I Van Walle
1European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
K Leitmeyer
1European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
E K Broberg
1European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
1European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Posted September 18, 2020.
Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
I Van Walle, K Leitmeyer, E K Broberg
medRxiv 2020.09.16.20195917; doi: https://doi.org/10.1101/2020.09.16.20195917
Subject Area
Subject Areas
- Addiction Medicine (415)
- Allergy and Immunology (736)
- Anesthesia (216)
- Cardiovascular Medicine (3153)
- Dermatology (268)
- Emergency Medicine (468)
- Epidemiology (13119)
- Forensic Medicine (15)
- Gastroenterology (876)
- Genetic and Genomic Medicine (4943)
- Geriatric Medicine (455)
- Health Economics (758)
- Health Informatics (3110)
- Health Policy (1110)
- Hematology (415)
- HIV/AIDS (983)
- Medical Education (460)
- Medical Ethics (121)
- Nephrology (508)
- Neurology (4696)
- Nursing (249)
- Nutrition (695)
- Oncology (2422)
- Ophthalmology (689)
- Orthopedics (271)
- Otolaryngology (334)
- Pain Medicine (313)
- Palliative Medicine (88)
- Pathology (523)
- Pediatrics (1258)
- Primary Care Research (530)
- Public and Global Health (7263)
- Radiology and Imaging (1623)
- Respiratory Medicine (950)
- Rheumatology (464)
- Sports Medicine (408)
- Surgery (525)
- Toxicology (66)
- Transplantation (223)
- Urology (193)